246 related articles for article (PubMed ID: 34296707)
1. Lifetime incremental cost-utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis.
Crawford EJ; Ravinsky RA; Coyte PC; Rampersaud YR
Can J Surg; 2021 Jul; 64(4):E391-E402. PubMed ID: 34296707
[TBL] [Abstract][Full Text] [Related]
2. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lifetime incremental cost:utility ratios of surgery relative to failed medical management for the treatment of hip, knee and spine osteoarthritis modelled using 2-year postsurgical values.
Tso P; Walker K; Mahomed N; Coyte PC; Rampersaud YR
Can J Surg; 2012 Jun; 55(3):181-90. PubMed ID: 22630061
[TBL] [Abstract][Full Text] [Related]
4. Comparative outcomes and cost-utility after surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee--part 1: long-term change in health-related quality of life.
Rampersaud YR; Lewis SJ; Davey JR; Gandhi R; Mahomed NN
Spine J; 2014 Feb; 14(2):234-43. PubMed ID: 24325880
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility of lumbar decompression with or without fusion for patients with symptomatic degenerative lumbar spondylolisthesis.
Kim S; Mortaz Hedjri S; Coyte PC; Rampersaud YR
Spine J; 2012 Jan; 12(1):44-54. PubMed ID: 22169001
[TBL] [Abstract][Full Text] [Related]
6. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
Rampersaud YR; Ravi B; Lewis SJ; Stas V; Barron R; Davey R; Mahomed N
Spine J; 2008; 8(2):296-304. PubMed ID: 17669690
[TBL] [Abstract][Full Text] [Related]
7. Cost-Utility Analysis of Instrumented Fusion Versus Decompression Alone for Grade I L4-L5 Spondylolisthesis at 1-Year Follow-up: A Pilot Study.
Alvin MD; Lubelski D; Abdullah KG; Whitmore RG; Benzel EC; Mroz TE
Clin Spine Surg; 2016 Mar; 29(2):E80-6. PubMed ID: 26889996
[TBL] [Abstract][Full Text] [Related]
8. Postoperative improvement in health-related quality of life: a national comparison of surgical treatment for focal (one- to two-level) lumbar spinal stenosis compared with total joint arthroplasty for osteoarthritis.
Rampersaud YR; Wai EK; Fisher CG; Yee AJ; Dvorak MF; Finkelstein JA; Gandhi R; Abraham EP; Lewis SJ; Alexander DI; Oxner WM; Davey JR; Mahomed N
Spine J; 2011 Nov; 11(11):1033-41. PubMed ID: 22122836
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years.
Parker SL; Adogwa O; Bydon A; Cheng J; McGirt MJ
World Neurosurg; 2012 Jul; 78(1-2):178-84. PubMed ID: 22120269
[TBL] [Abstract][Full Text] [Related]
10. Understanding the value of minimally invasive procedures for the treatment of lumbar spinal stenosis: the case of interspinous spacer devices.
Tapp SJ; Martin BI; Tosteson TD; Lurie JD; Weinstein MC; Deyo RA; Mirza SK; Tosteson ANA
Spine J; 2018 Apr; 18(4):584-592. PubMed ID: 28847740
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of open transforaminal lumbar interbody fusion (OTLIF) versus minimally invasive transforaminal lumbar interbody fusion (MITLIF): a systematic review and meta-analysis.
Droeghaag R; Hermans SMM; Caelers IJMH; Evers SMAA; van Hemert WLW; van Santbrink H
Spine J; 2021 Jun; 21(6):945-954. PubMed ID: 33493680
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of direct costs, outcomes, and cost-utility of decompression surgery with fusion versus decompression alone for degenerative lumbar spondylolisthesis.
Yagi M; Fujita N; Okada E; Tsuji O; Nagoshi N; Tsuji T; Nakamura M; Matsumoto M; Watanabe K
J Orthop Sci; 2018 Jul; 23(4):653-657. PubMed ID: 29699906
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness for Surgical Treatment of Degenerative Spondylolisthesis.
Jones KE; Polly DW
Neurosurg Clin N Am; 2019 Jul; 30(3):365-372. PubMed ID: 31078237
[TBL] [Abstract][Full Text] [Related]
14. Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention.
Adogwa O; Parker SL; Shau DN; Mendenhall SK; Aaronson O; Cheng JS; Devin CJ; McGirt MJ
J Neurosurg Spine; 2012 Feb; 16(2):135-40. PubMed ID: 22054639
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life: a comparison of outcomes after lumbar fusion for degenerative spondylolisthesis with large joint replacement surgery and population norms.
Mokhtar SA; McCombe PF; Williamson OD; Morgan MK; White GJ; Sears WR
Spine J; 2010 Apr; 10(4):306-12. PubMed ID: 20362246
[TBL] [Abstract][Full Text] [Related]
16. A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis.
Chan AK; Bisson EF; Bydon M; Glassman SD; Foley KT; Potts EA; Shaffrey CI; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; Mummaneni PV
Neurosurg Focus; 2019 May; 46(5):E13. PubMed ID: 31042655
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis: comparative effectiveness and cost-utility analysis.
Parker SL; Mendenhall SK; Shau DN; Zuckerman SL; Godil SS; Cheng JS; McGirt MJ
World Neurosurg; 2014; 82(1-2):230-8. PubMed ID: 23321379
[TBL] [Abstract][Full Text] [Related]
18. Revision lumbar surgery in elderly patients with symptomatic pseudarthrosis, adjacent-segment disease, or same-level recurrent stenosis. Part 2. A cost-effectiveness analysis: clinical article.
Adogwa O; Owens R; Karikari I; Agarwal V; Gottfried ON; Bagley CA; Isaacs RE; Cheng JS
J Neurosurg Spine; 2013 Feb; 18(2):147-53. PubMed ID: 23231358
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of lumbar discectomy and single-level fusion for spondylolisthesis: experience with the NeuroPoint-SD registry.
Mummaneni PV; Whitmore RG; Curran JN; Ziewacz JE; Wadhwa R; Shaffrey CI; Asher AL; Heary RF; Cheng JS; Hurlbert RJ; Douglas AF; Smith JS; Malhotra NR; Dante SJ; Magge SN; Kaiser MG; Abbed KM; Resnick DK; Ghogawala Z
Neurosurg Focus; 2014 Jun; 36(6):E3. PubMed ID: 24881635
[TBL] [Abstract][Full Text] [Related]
20. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
